Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate

Treatment Effect of Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate as Classified by Electro-retinal Responses

Our project is a 24-month longitudinal randomized controlled trial that aims to investigate the myopia development after topical application of 0.01% atropine in children with either fast or slow myopia progression classified according to their initial electro-retinal responses. This will help elucidate the effectiveness of using low concentration atropine for myopia control in children with different myopia progression rates.

Inclusion Criteria:

• Age between 7 and 10 years
• Good general health and no family history of ocular diseases
• No current or history of epilepsy or asthma
• Myopia : -0.50 to -1.00 D (inclusive, both eyes)
• Astigmatism : ≤ 0.50 D
• No hyperopia, amblyopia or strabismus
• No reported ocular eye diseases or disorders
• No drug allergy